This inventor holds 1 USPTO granted patent and 5 published patent applications and 2 EPO patents. Top assignee: Schering Corporation. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Madhu Chintala: Innovator in Thrombin Receptor Antagonists
Introduction
Madhu Chintala is a notable inventor based in Colts Neck, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of thrombin receptor antagonists. His work has implications for various therapeutic applications.
Latest Patents
Chintala holds a patent for "Constrained himbacine analogs as thrombin receptor antagonists." This patent describes a compound represented by a specific structural formula. It also discloses pharmaceutical compositions and combinations containing these compounds, highlighting their uses as thrombin receptor antagonists and binders to cannabinoid receptors. He has 1 patent to his name.
Career Highlights
Throughout his career, Madhu Chintala has worked with prominent companies in the pharmaceutical industry. He has been associated with Schering Corporation and Merck Sharp & Dohme Corp. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Chintala has collaborated with several professionals in his field, including Mariappan Chelliah and Samuel Chackalamannil. These collaborations have likely enriched his research and development efforts.
Conclusion
Madhu Chintala's work in the pharmaceutical industry, particularly in thrombin receptor antagonists, showcases his innovative spirit and dedication to advancing medical science. His contributions are valuable to the ongoing development of therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile